Animal studies on MS models have revealed that fibrinogen can contribute to neuroinflammation and axonal injury by inducing the clustering of microglia around blood vessels and the excessive release of ROS and NO intermediates through CD11b/CD18 binding (Davalos et al., 2012). The gene discussed is ITGB2; the disease is myeloid sarcoma.